Klinikum Kempten - Oberallgaeu
Kempten, Germany
General hospital in Kempten, Bavaria
Robert-Weixler-Straße 50, 87439 Kempten (Allgäu)
About Klinikum Kempten - Oberallgaeu
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
3
German CLL Study Group
2
Heidelberg University
2
Hoffmann-La Roche
2
AGO Research GmbH
1
Ariad Pharmaceuticals
1
Deutsches Herzzentrum Muenchen
1
European LeukemiaNet
1
III. Medizinische Klinik Mannheim
1
Karolinska University Hospital
1
Medtronic Spine LLC
1
Clinical Trials at Klinikum Kempten - Oberallgaeu
During the past decade, Klinikum Kempten - Oberallgaeu conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
1999-07-01
2007-07-01
Completed
375
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
2005-11-01
2018-08-01
Completed
592
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
2004-09-01
2010-10-01
Completed
97
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Kempten - Oberallgaeu" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials, followed by "German CLL Study Group" with 2 trials
sponsored, "Heidelberg University" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "AGO Research GmbH"
with 2 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Kempten - Oberallgaeu"
#1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Klinikum Kempten - Oberallgaeu
According to Clinical.Site data, the most researched conditions in "Klinikum Kempten - Oberallgaeu" are
"Leukemia" (3 trials), "Lymphoma" (3 trials), "Breast Cancer" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials) and "Chronic Myeloid Leukemia" (2 trials). Many other conditions were trialed in "Klinikum Kempten - Oberallgaeu" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Kempten - Oberallgaeu
Most popular intervention types in "Klinikum Kempten - Oberallgaeu" are "Drug" (18 trials), "Biological" (7 trials), "Other" (5 trials), "Radiation" (4 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (3 trials), "prednisone" (3 trials), "radiation therapy" (3 trials) and "rituximab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Kempten - Oberallgaeu
The vast majority of trials in "Klinikum Kempten - Oberallgaeu" are
18 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Klinikum Kempten - Oberallgaeu
Currently, there are NaN active trials in "Klinikum Kempten - Oberallgaeu".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Klinikum Kempten - Oberallgaeu,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Kempten - Oberallgaeu, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".